New York State Common Retirement Fund reduced its stake in shares of SAGE Therapeutics Inc (NASDAQ:SAGE) by 10.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 192,879 shares of the biopharmaceutical company’s stock after selling 22,333 shares during the period. New York […]
